Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 22, 2022
FUJIFILM Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scientific,
read more
FUJIFILM Irvine Scientific announced plans to open a third manufacturing facility located in Tilburg, Netherlands.
read more
Thursday, September 30, 2021
FUJIFILM Irvine Scientific, Inc., announced that it completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility ...
read more
Wednesday, December 01, 2021
FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the establishment of an Innovation and ...
read more
Monday, December 14, 2020
FUJIFILM Irvine Scientific has announced the launch of Sterile Express Media Service (SEMS), for small-scale, rapid production of non-GMP media tested for sterility.
read more
Wednesday, December 08, 2021
FUJIFILM Irvine Scientific, Inc., announced that its new manufacturing facility in Tilburg, the Netherlands is now open and fully operational. The facility provides state-of-the-art Life Science manufacturing and joins locations in the U.S. and Japan...
read more
FUJIFILM Irvine has become the exclusive, worldwide distributor of cellnest, a recombinant peptide attachment substrate.
read more
FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for life ...
read more
Wednesday, March 23, 2022
Shenandoah Biotechnology is a privately held company located in Warminster, Pennsylvania, that manufactures recombinant proteins including cytokines and growth factors. Shenandoah Biotechnology recently launched their CTG Grade™ line of cytokines and...
read more
FUJIFILM announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in order to expand its Bio CDMO Business.
read more
Wednesday, November 11, 2020
Centogene and Fujirebio Europe have entered a partnership to leverage LUMIPULSE G technology for large-scale COVID-19 antigen testing with further deployment in German airports.
read more
Vetter announced the commissioning of a new warehouse designed to help meet increasing customer market supply demands. With a total investment of approx.
read more
Thursday, December 10, 2020
Fusion Antibodies and Queen’s University Belfast have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.
read more
Wednesday, September 20, 2023
Future Fields, a biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protein production, announced the launch of its contract development and manufacturing organization (CDMO) service.
read more
G&W Laboratories has announced the appointment of Jay Galeotato the position of President and Chief Operating Officer. Mr. Galeota joins G&W following a 28-year career at Merck, where he was most recently Chief Strategy & Business Development Officer...
read more